toremifene
Meaning of toremifene: A close chemical relative of tamoxifen, differing by a single chlorine atom, prescribed for advanced hormone-sensitive breast cancer.
Definition of toremifene
Toremifene is a selective estrogen receptor modulator taken by mouth for advanced breast cancer that depends on estrogen for growth. It occupies estrogen receptors in breast tissue and shuts down the growth signal there, while behaving like a weak estrogen in bone and in the lining of the uterus. Its approved use is in advanced disease in women who have passed the menopause.
Is it an antiestrogen?
Only in part, and the shorter label hides how the drug works. Toremifene binds the estrogen receptor and then behaves differently depending on which tissue the receptor sits in. In breast tissue it blocks, silencing the signal a hormone-driven tumor depends on. In bone and in the lining of the uterus it does the opposite and acts as a weak estrogen. That split is exactly what the phrase selective estrogen receptor modulator describes, and it accounts for the useful effects and the unwanted ones alike. Drugs that block the receptor in every tissue, or that break it down altogether, form a separate class and behave differently in bone.
How does it compare with tamoxifen?
| Feature | Toremifene | Tamoxifen |
|---|---|---|
| Chemistry | Tamoxifen with one chlorine added | The parent compound |
| Approved use | Advanced disease after menopause | Advanced and early disease, before or after |
| Tissue pattern | Blocks breast, mimics estrogen in bone and uterus | The same pattern |
| Flagged hazard | Dose-related lengthening of the QT interval | Uterine cancer and clots |
Comparative trials in advanced disease have found the two similar in response, and a tumor that has stopped responding to one rarely responds to the other, because the mechanism is shared. That cross-resistance is the practical reason the drug is not simply the next thing tried after tamoxifen stops working.
What are its main drawbacks?
Hot flashes and sweating are the commonest complaints, followed by nausea, vaginal discharge and dizziness. Because it acts like estrogen in the uterus, thickening of the lining and, uncommonly, uterine cancer are recognized concerns, as is a raised chance of clots in the legs and lungs. The effect on heart rhythm sets it apart from its parent: it lengthens the QT interval in a dose-related way, which carries most weight alongside other drugs doing the same or where blood potassium or magnesium runs low. Where cancer has spread to bone, blood calcium can climb sharply in the early weeks of treatment.
Also known as
Used in a sentence
Toremifene was started for estrogen receptor positive metastatic breast cancer.
Good to know
Toremifene blocks the estrogen signal in breast tissue while behaving like a weak estrogen in bone and the uterine lining, and it lengthens the QT interval on the electrocardiogram in a dose-related way.